Predicting Factors for a Favorable Pathologic Response to Neoadjuvant Therapy in Esophageal Cancer.

Ory Wiesel,Oran Zlotnik,Sarah Morgenstern, Maya Tsur,Nikolai Menasherov,Yael Feferman,Irit Ben-Aharon,Hanoch Kashtan

American journal of clinical oncology（2022）

引用 0|浏览3

暂无评分

摘要

FPR is a predictor of improved OS. SCC and radiation therapy-based protocol were identified as major prediction factors of FPR in patients with esophageal and GEJ cancers.

查看译文

关键词

esophageal cancer, gastroesophageal junction cancer, tumor regression grade, favorable pathologic response, esophagectomy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要